Personal information

Countries

Switzerland

Activities

Collapse all

Employment (8)

University Hospital of Zurich: Zurich, Zurich, CH

2023-03-01 to present | Leitende Ärztin (chief of service) (Endocrinology, Diabetes & Metabolism)
Employment
Source: Self-asserted source
Claudia Cavelti-Weder

University of Basel: Basel, Basel-Stadt, CH

2015-02 to present | Group leader (Department of Biomedicine)
Employment
Source: Self-asserted source
Claudia Cavelti-Weder

University Hospital of Zurich: Zurich, Zurich, CH

2020-10 to 2023-02 | Attending Physician (Oberärztin meV) (Endocrinology, Diabetes & Metabolism)
Employment
Source: Self-asserted source
Claudia Cavelti-Weder

University Hospital of Basel: Basel, Basel-Stadt, CH

2014-07 to 2020-07 | Attending physician (Endocrinology, Diabetes & Metabolism)
Employment
Source: Self-asserted source
Claudia Cavelti-Weder

University Hospital of Zurich: Zurich, Zurich, CH

2013-02 to 2014-05 | Fellow (Endocrinology, Diabetes & Nutrition)
Employment
Source: Self-asserted source
Claudia Cavelti-Weder

Harvard University: Cambridge, MA, US

2010-01 to 2012-10 | Postdoctoral Fellow (Joslin Diabetes Center)
Employment
Source: Self-asserted source
Claudia Cavelti-Weder

University Hospital of Zurich: Zurich, Zurich, CH

2007-02 to 2009-12 | Fellow (Internal Medicine)
Employment
Source: Self-asserted source
Claudia Cavelti-Weder

Hospital of Bülach: Bülach, Zurich, CH

2005-02 to 2007-01 | Resident (Internal Medicine)
Employment
Source: Self-asserted source
Claudia Cavelti-Weder

Education and qualifications (7)

University of Zurich: Zurich, Zurich, CH

2022-06 to present | PD (Habilitation) (Endocrinology, Diabetology and Clinical Nutrition)
Qualification
Source: Self-asserted source
Claudia Cavelti-Weder

University of Basel: Basel, Basel-Stadt, CH

2016-05 to present | PD (Habilitation) (Endocrinology, Diabetes & Metabolism)
Qualification
Source: Self-asserted source
Claudia Cavelti-Weder

FMH Endocrinology, Swiss Medical Association: Bern, CH

2014-06 to present | FMH Endocrinology
Qualification
Source: Self-asserted source
Claudia Cavelti-Weder

FMH Internal Medicine, Swiss Medical Association: Bern, CH

2011-09 to present | FMH Internal Medicine
Qualification
Source: Self-asserted source
Claudia Cavelti-Weder

University of Basel: Basel, Basel-Stadt, CH

2005-09-02 to present | MD thesis
Qualification
Source: Self-asserted source
Claudia Cavelti-Weder

Swiss Federal Diploma of Physician: Bern, CH

2004-11-24 to present
Qualification
Source: Self-asserted source
Claudia Cavelti-Weder

Harvard University: Cambridge, MA, US

2011-07 to 2013-11 | MPH (Master of Public Health) (Harvard T.H. Chan School of Public Health)
Qualification
Source: Self-asserted source
Claudia Cavelti-Weder

Professional activities (10)

EASD Young Academy: Düsseldorf, Nordrhein-Westfalen, DE

2022-01 to present | Founding member
Membership
Source: Self-asserted source
Claudia Cavelti-Weder

European Association for the Study of Diabetes: Düsseldorf, Nordrhein-Westfalen, DE

2019 to present
Membership
Source: Self-asserted source
Claudia Cavelti-Weder

American Diabetes Association: Alexandria, VA, US

2016 to present
Membership
Source: Self-asserted source
Claudia Cavelti-Weder

Swiss Association for Endocrinology and Diabetes: Bern, Bern, CH

2013 to present
Membership
Source: Self-asserted source
Claudia Cavelti-Weder

Swiss Medical Association: Bern, Bern, CH

2008 to present
Membership
Source: Self-asserted source
Claudia Cavelti-Weder

Swiss Association for Medical Residents and Faculty: Bern, Bern, CH

2008 to present
Membership
Source: Self-asserted source
Claudia Cavelti-Weder

University of Basel: Basel, Basel-Stadt, CH

2018-01 | antelope medical professorship program
Distinction
Source: Self-asserted source
Claudia Cavelti-Weder

Swiss Diabetes Foundation: Baden, Baden, CH

2014-11 | Research prize 2014
Distinction
Source: Self-asserted source
Claudia Cavelti-Weder

Association for Women in Science: Boston, MA, US

2011 to 2012
Membership
Source: Self-asserted source
Claudia Cavelti-Weder

Fellows Council, Joslin Diabetes Center: Boston, MA, US

2010 to 2012
Membership
Source: Self-asserted source
Claudia Cavelti-Weder

Funding (26)

Swiss Multicenter Randomized Controlled Trial on different Limb Lengths in Gastric Bypass Surgery (SLIM)

2022-03-01 to 2026-02-28 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.10055449
GRANT_NUMBER: 204937
Source: Self-asserted source
Claudia Cavelti-Weder via DimensionsWizard

Swiss Multicentre Randomized Controlled Trial on different Limb Lengths in Gastric Bypass Surgery (SLIM)

2022-01 to 2025-12 | Salary award
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Bern, Bern, CH)
GRANT_NUMBER:

320038_204937 / 2

Source: Self-asserted source
Claudia Cavelti-Weder

Swiss Multicentre Randomized Controlled Trial on different Limb Lengths in Gastric Bypass Surgery (SLIM)

2022-01 to 2024-12 | Grant
Uniscientia Stiftung (Vaduz, LI)
Source: Self-asserted source
Claudia Cavelti-Weder

Comprehensive analysis of intestinal gut homeostasis before and after weight loss surgery

2022-01 to 2023-12 | Salary award
University of Zurich, «Filling the Gap» 2022-2023 – Siegenthaler Fellowship (Zurich, Zurich, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Air pollution-induced diabetes: Mechanistic role of intestinal macrophages in mice and humans

2021-01 to 2023-12 | Grant
Philhuman Stiftung (Zurich, Zurich, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

EFSD Mentorship Programme

2020 to 2023 | Award
European Foundation for the Study of Diabetes (Düsseldorf, Nordrhein-Westfalen, DE)
Source: Self-asserted source
Claudia Cavelti-Weder

Air pollution-induced diabetes: Could the gut play a role?

2019-07 to 2021-06 | Grant
OPO-Stiftung (Zürich, Zurich, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Air pollution-induced diabetes: Could the gut play a role?

2019-01 to 2022-12 | Grant
Vontobel-Stiftung (Zürich, Zurich, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Activation and metabolism status of macrophages in metabolic disease and potential impact of tyrosine kinase inhibitors (TKIs)

2018-09-01 to 2019-08-31 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.7823236
GRANT_NUMBER: 180472
Source: Self-asserted source
Claudia Cavelti-Weder via DimensionsWizard

Role of intestinal macrophages in air pollution-induced diabetes

2018-03 to present | Grant
Schweizerische Diabetes-Stiftung (Baden, Baden, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Gut and air pollution-induced diabetes: Do intestinal macrophages play a crucial role?

2017-12 to present | Grant
Wolfermann-Nägeli-Stiftung (Zurich, Zurich, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Air pollution as a major obstacle in healthy aging: Could the gut play a role?

2017-11 to 2021-10 | Grant
Velux Stiftung (Zürich, Zurich, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

The gastrointestinal tract’s role in mediating air pollution-induced metabolic disease

2016-08 to present | Grant
Schweiz. Gesellschaft für Endokrinologie und Diabetologie (SGED), Young Independent Investigator Research Grant (Bern, Bern, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Characterization of intestinal macrophages in metabolic disease (subproject 1) & Potential role of tyrosine kinase inhibitors (TKIs) on macrophage polarization (subproject 2)

2016-06 to present | Grant
Jubiläumsstiftung von Swiss Life (Zurich, Zurich, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Characterization of intestinal macrophages in metabolic disease (subproject 1) & Potential role of tyrosine kinase inhibitors (TKIs) on macrophage polarization (subproject 2)

2016-02 to present | Grant
Olga Mayenfisch Stiftung (Zurich, Zurich, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Characterization and targeting of macrophage polarization in obesity and type 2 diabetes

2015-10 to present | Grant
Fonds der Basler Diabetesgesellschaft (Basel, Basel-Stadt, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Activation and metabolism status of macrophages in metabolic disease and potential impact of tyrosine kinase inhibitors (TKIs)

2015-09-01 to 2018-08-31 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.5239003
GRANT_NUMBER: 161135
Source: Self-asserted source
Claudia Cavelti-Weder via DimensionsWizard

Activation and metabolism status of macrophages in metabolic disease and potential impact of tyrosine kinase inhibitors (TKIs)

2015-05 to present | Grant
Forschungsfonds, Förderung exzellente Nachwuchsforschende (Basel, Basel-Stadt, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Activation and metabolism status of macrophages in metabolic disease and potential impact of tyrosine kinase inhibitors (TKIs)

2015-05 to present | Grant
Freiwillige Akademische Gesellschaft (Basel, Basel-Stadt, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Activation and metabolism status of macrophages in metabolic disease and potential impact of tyrosine kinase inhibitors (TKIs)

2015-04 to present | Grant
Novartis Foundation (Basel, Basel-Stadt, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Activation and metabolism status of macrophages in metabolic disease and potential impact of tyrosine kinase inhibitors (TKIs) ial impact of tyrosine kinase inhibitors (TKIs)

2015-03 to present | Grant
Gottfried und Julia Bangerter-Rhyner-Stiftung (Basel, Basel-Stadt, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes.

2015-01 to present | Grant
Nachwuchsförderung, VFWAWF-Pool University Hospital Basel (Basel, Basel-Stadt, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Activation and metabolism status of macrophages in metabolic disease and potential impact of tyrosine kinase inhibitors (TKIs)

2014-12 to 2018-08 | Grant
Goldschmidt-Jacobson Foundation, Bed to Bench for Top Clinicians (Basel, Basel-Stadt, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

Scholarship Clinical Medicine Plus

2013 to 2013 | Award
Stiftung Professor Dr. Max Cloëtta (Zurich, Zurich, CH)
Source: Self-asserted source
Claudia Cavelti-Weder

TWO APPROACHES TO BETA-CELL REGENERATION: Reprogramming and Regeneration after Almost Complete Beta-Cell Loss

2011-07-01 to 2012-06-30 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.5232128
GRANT_NUMBER: 136978
Source: Self-asserted source
Claudia Cavelti-Weder via DimensionsWizard

Regeneration of human B-cells

2010-02-01 to 2011-07-31 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.5218690
GRANT_NUMBER: 130990
Source: Self-asserted source
Claudia Cavelti-Weder via DimensionsWizard

Works (35)

Real-world evidence supporting the use of advanced hybrid closed loop in poorly controlled type 1 diabetes patients

Diabetes Research and Clinical Practice
2025-02 | Journal article
DOI: 10.1016/j.diabres.2025.112035
Contributors: Sophie Graf; Giulia Hofer; Ruth Hirschmann; Roger Lehmann; Claudia Cavelti-Weder
Source: check_circle
Crossref

Family planning, reproductive health and pregnancy after bariatric surgery: a survey of bariatric healthcare professionals in Switzerland

Swiss Medical Weekly
2024-12-04 | Journal article
DOI: 10.57187/s.3841
Contributors: Ioannis I. Lazaridis; Sofya Lukovnikova; Georgios Peros; Andreas Andreou; Diana Mattiello; Thomas Köstler; Dimitrios Schizas; Urs Zingg; Claudia Cavelti-Weder; Tarik Delko
Source: check_circle
Crossref

CSF1R inhibition with PLX5622 affects multiple immune cell compartments and induces tissue-specific metabolic effects in lean mice

Diabetologia
2023-10-04 | Journal article | Author
DOI: 10.1007/s00125-023-06007-1
Part of ISSN: 0012-186X
Part of ISSN: 1432-0428
Contributors: Angela Bosch; Lena Keller; Laura Steiger; Theresa V. Rohm; Sophia Julia Wiedemann; Andy J. Y. Low; Marc Stawiski; Leila Rachid; Julien Roux; Daniel Konrad et al.
Source: Self-asserted source
Claudia Cavelti-Weder

Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases

The Lancet Diabetes & Endocrinology
2023-09 | Journal article
DOI: 10.1016/s2213-8587(23)00154-7
Part of ISSN: 2213-8587
Contributors: Nikolaos Perakakis; Hani Harb; Benjamin G Hale; Zsuzsanna Varga; Charlotte Steenblock; Waldemar Kanczkowski; Vasileia Ismini Alexaki; Barbara Ludwig; Peter Mirtschink; Michele Solimena et al.
Source: Self-asserted source
Claudia Cavelti-Weder

Diesel Exhaust Particle (DEP)-induced glucose intolerance is driven by an intestinal innate immune response and NLRP3 activation in mice.

Particle and fibre toxicology
2023-07 | Journal article
DOI: 10.1186/s12989-023-00536-8
PMID: 37400850
Contributors: Bosch AJT; Rohm TV; AlAsfoor S; Low AJY; Baumann Z; Parayil N; Noreen F; Roux J; Meier DT; Cavelti-Weder C
Source: Self-asserted source
Claudia Cavelti-Weder via Europe PubMed Central

Lung versus gut exposure to air pollution particles differentially affect metabolic health in mice.

Particle and fibre toxicology
2023-03 | Journal article
DOI: 10.1186/s12989-023-00518-w
PMID: 36895000
PMC: PMC9996885
Contributors: Bosch AJT; Rohm TV; AlAsfoor S; Low AJY; Keller L; Baumann Z; Parayil N; Stawiski M; Rachid L; Dervos T et al.
Source: Self-asserted source
Claudia Cavelti-Weder via Europe PubMed Central

Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial

eClinicalMedicine
2022-11 | Journal article
DOI: 10.1016/j.eclinm.2022.101649
Part of ISSN: 2589-5370
Contributors: Claudia Cavelti-Weder
Source: Self-asserted source
Claudia Cavelti-Weder

Liver, NAFLD and COVID-19

Hormone and Metabolic Research
2022-08 | Journal article
DOI: 10.1055/a-1834-9008
Part of ISSN: 0018-5043
Part of ISSN: 1439-4286
Contributors: Claudia Cavelti-Weder
Source: Self-asserted source
Claudia Cavelti-Weder

Roux-en-Y gastric bypass with a long versus a short biliopancreatic limb improves weight loss and glycemic control in obese mice

Surgery for Obesity and Related Diseases
2022-06 | Journal article
DOI: 10.1016/j.soard.2022.06.286
Part of ISSN: 1550-7289
Contributors: Claudia Cavelti-Weder
Source: Self-asserted source
Claudia Cavelti-Weder

Glucagon-like peptide-1 receptor PET/CT in patients with and without post gastric bypass hypoglycemia – a prospective, matched case-control study

2022-04 | Preprint
DOI: 10.21203/rs.3.rs-1561857/v1
PPR: PPR486196
Contributors: Hepprich M; Antwi K; Wiesner P; Cavelti-Weder C; Donath MY; Christ ER; Wild D
Source: Self-asserted source
Claudia Cavelti-Weder via Europe PubMed Central

Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity.

Communications biology
2022-04-19 | Journal article
DOI: 10.1038/s42003-022-03305-z
PMID: 35440795
PMC: PMC9018739
Source: Self-asserted source
Claudia Cavelti-Weder

Epithelial GPR35 protects from Citrobacter rodentium infection by preserving goblet cells and mucosal barrier integrity.

Mucosal immunology
2022-03-09 | Journal article
DOI: 10.1038/s41385-022-00494-y
PMID: 35264769
PMC: PMC9038528
Source: Self-asserted source
Claudia Cavelti-Weder

Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation.

Frontiers in immunology
2021-05 | Journal article
DOI: 10.3389/fimmu.2021.668654
PMID: 34054838
PMC: PMC8158297
Contributors: Rohm TV; Fuchs R; Müller RL; Keller L; Baumann Z; Bosch AJT; Schneider R; Labes D; Langer I; Pilz JB et al.
Source: Self-asserted source
Claudia Cavelti-Weder via Europe PubMed Central

GLP-1 Analogues as a Complementary Therapy in Patients after Metabolic Surgery: a Systematic Review and Qualitative Synthesis

Obesity Surgery
2020-09 | Journal article
DOI: 10.1007/s11695-020-04750-7
Part of ISSN: 0960-8923
Part of ISSN: 1708-0428
Contributors: Claudia Cavelti-Weder
Source: Self-asserted source
Claudia Cavelti-Weder

Case Report-Secondary Antibody Deficiency Due to Endogenous Hypercortisolism.

Frontiers in immunology
2020-07 | Journal article
DOI: 10.3389/fimmu.2020.01435
PMID: 32733476
PMC: PMC7358340
Contributors: Sarcevic J; Cavelti-Weder C; Berger CT; Trendelenburg M
Source: Self-asserted source
Claudia Cavelti-Weder via Europe PubMed Central

Treatment of Primary Aldosteronism With mTORC1 Inhibitors

The Journal of Clinical Endocrinology & Metabolism
2019-10-01 | Journal article
DOI: 10.1210/jc.2019-00563
Part of ISSN: 0021-972X
Part of ISSN: 1945-7197
Contributors: Claudia Cavelti-Weder
Source: Self-asserted source
Claudia Cavelti-Weder

Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver

Scientific Reports
2018-12 | Journal article
DOI: 10.1038/s41598-018-32853-w
Part of ISSN: 2045-2322
Contributors: Claudia Cavelti-Weder
Source: Self-asserted source
Claudia Cavelti-Weder

AZ-Verschlechterung unter tuberkulostatischer Therapie

Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
2017-10 | Journal article
DOI: 10.4414/smf.2017.03087
Part of ISSN: 1424-4020
Contributors: Sabina Brigitte Streuli; Claudia Cavelti-Weder; Fabian Meienberg; Claudia Bühler; Peter Grendelmeier
Source: Self-asserted source
Claudia Cavelti-Weder via Crossref Metadata Search

Reprogramming of Pancreatic Acinar Cells to Functional Beta Cells by In Vivo Transduction of a Polycistronic Construct Containing Pdx1, Ngn3, MafA in Mice

Current Protocols in Stem Cell Biology
2017-02 | Journal article
DOI: 10.1002/cpsc.21
Part of ISSN: 1941-7322
Part of ISSN: 1938-8969
Contributors: Claudia Cavelti-Weder
Source: Self-asserted source
Claudia Cavelti-Weder

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes

Molecular Therapy
2016-05 | Journal article
DOI: 10.1038/mt.2015.227
Part of ISSN: 1525-0016
Contributors: Claudia Cavelti-Weder; Katharina Timper; Eleonora Seelig; Cornelia Keller; Martin Osranek; Ute Lässing; Gunther Spohn; Patrik Maurer; Philipp Müller; Gary T Jennings et al.
Source: Self-asserted source
Claudia Cavelti-Weder via Crossref Metadata Search

Hyperglycaemia attenuates in vivo reprogramming of pancreatic exocrine cells to beta cells in mice

Diabetologia
2016-03 | Journal article
DOI: 10.1007/s00125-015-3838-7
Part of ISSN: 0012-186X
Part of ISSN: 1432-0428
Contributors: Claudia Cavelti-Weder
Source: Self-asserted source
Claudia Cavelti-Weder

Reprogramming Mouse Cells With a Pancreatic Duct Phenotype to Insulin-Producing β-Like Cells

Endocrinology
2015-06-01 | Journal article
DOI: 10.1210/en.2014-1987
Part of ISSN: 0013-7227
Part of ISSN: 1945-7170
Contributors: Claudia Cavelti-Weder
Source: Self-asserted source
Claudia Cavelti-Weder

Direct Reprogramming for Pancreatic Beta-Cells Using Key Developmental Genes

Current Pathobiology Reports
2015-01 | Journal article
DOI: 10.1007/s40139-015-0068-0
Part of ISSN: 2167-485X
Contributors: Claudia Cavelti-Weder; Weida Li; Adrian Zumsteg; Marianne Stemann; Takatsugu Yamada; Susan Bonner-Weir; Gordon Weir; Qiao Zhou
Source: Self-asserted source
Claudia Cavelti-Weder via Crossref Metadata Search

Direct Lineage Conversion of Pancreatic Exocrine to Endocrine Beta Cells In Vivo with Defined Factors

Methods in Molecular Biology
2014 | Book chapter
DOI: 10.1007/978-1-4939-0512-6_17
Part of ISBN: 9781493905119
Part of ISBN: 9781493905126
Part of ISSN: 1064-3745
Part of ISSN: 1940-6029
Contributors: Claudia Cavelti-Weder
Source: Self-asserted source
Claudia Cavelti-Weder

Long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells

Nature Biotechnology
2014-12 | Journal article
DOI: 10.1038/nbt.3082
Part of ISSN: 1087-0156
Part of ISSN: 1546-1696
Contributors: Claudia Cavelti-Weder
Source: Self-asserted source
Claudia Cavelti-Weder

Pancreatic Duct Ligation After Almost Complete β-Cell Loss: Exocrine Regeneration but No Evidence of β-Cell Regeneration

Endocrinology
2013-12-01 | Journal article
DOI: 10.1210/en.2013-1463
Part of ISSN: 0013-7227
Part of ISSN: 1945-7170
Contributors: Claudia Cavelti-Weder
Source: Self-asserted source
Claudia Cavelti-Weder

Identification of a SIRT1 Mutation in a Family with Type 1 Diabetes

Cell Metabolism
2013-03 | Journal article
DOI: 10.1016/j.cmet.2013.02.001
Part of ISSN: 1550-4131
Contributors: Anna Biason-Lauber; Marianne Böni-Schnetzler; Basil P. Hubbard; Karim Bouzakri; Andrea Brunner; Claudia Cavelti-Weder; Cornelia Keller; Monika Meyer-Böni; Daniel T. Meier; Caroline Brorsson et al.
Source: Self-asserted source
Claudia Cavelti-Weder via Crossref Metadata Search

Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes

Diabetes Care
2012-06 | Journal article
DOI: 10.2337/dc11-2219
Part of ISSN: 0149-5992
Contributors: C. Cavelti-Weder; A. Babians-Brunner; C. Keller; M. A. Stahel; M. Kurz-Levin; H. Zayed; A. M. Solinger; T. Mandrup-Poulsen; C. A. Dinarello; M. Y. Donath
Source: Self-asserted source
Claudia Cavelti-Weder via Crossref Metadata Search

Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy

Diabetes Care
2012-05 | Journal article
DOI: 10.2337/dc12-0115
Part of ISSN: 0149-5992
Contributors: C. Cavelti-Weder; B. Muggli; C. Keller; A. Babians-Brunner; A. Biason-Lauber; M. Y. Donath; P. Schmid-Grendelmeier
Source: Self-asserted source
Claudia Cavelti-Weder via Crossref Metadata Search

Stem cell approaches for diabetes: towards beta cell replacement

Genome Medicine
2011 | Journal article
DOI: 10.1186/gm277
Part of ISSN: 1756-994X
Contributors: Gordon C Weir; Claudia Cavelti-Weder; Susan Bonner-Weir
Source: Self-asserted source
Claudia Cavelti-Weder via Crossref Metadata Search

Inhibition of IL-1  Improves Fatigue in Type 2 Diabetes

Diabetes Care
2011-09 | Journal article
DOI: 10.2337/dc11-1196
Part of ISSN: 0149-5992
Contributors: C. Cavelti-Weder; R. Furrer; C. Keller; A. Babians-Brunner; A. M. Solinger; H. Gast; A. Fontana; M. Y. Donath; I. K. Penner
Source: Self-asserted source
Claudia Cavelti-Weder via Crossref Metadata Search

Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate

Kidney International
2011-01 | Journal article
DOI: 10.1038/ki.2010.375
Part of ISSN: 0085-2538
Contributors: Ivana Pavik; Philippe Jaeger; Andreas D. Kistler; Diane Poster; Fabienne Krauer; Claudia Cavelti-Weder; Katharina M. Rentsch; Rudolf P. Wüthrich; Andreas L. Serra
Source: Self-asserted source
Claudia Cavelti-Weder via Crossref Metadata Search

Triptans and troponin: a case report

Orphanet Journal of Rare Diseases
2009 | Journal article
DOI: 10.1186/1750-1172-4-15
Part of ISSN: 1750-1172
Contributors: Claudia R Weder; Markus Schneemann
Source: Self-asserted source
Claudia Cavelti-Weder via Crossref Metadata Search

Sind Typ-1- und Typ-2-Diabetes die gleiche Krankheit?

Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
2009-05 | Journal article
DOI: 10.4414/smf.2009.06822
Part of ISSN: 1424-4020
Contributors: MY Donath; C Weder; A Brunner; C Keller; P Zala; B Schwegler
Source: Self-asserted source
Claudia Cavelti-Weder via Crossref Metadata Search

Clinical and immune responses correlate in glatiramer acetate therapy of multiple sclerosis

European Journal of Neurology
2005-11 | Journal article
DOI: 10.1111/j.1468-1331.2005.01084.x
Part of ISSN: 1351-5101
Contributors: C. Weder; G. M. Baltariu; K. A. Wyler; H.-J. Gober; C. Lienert; M. Schluep; E. W. Radu; G. Libero; L. Kappos; P. W. Duda
Source: Self-asserted source
Claudia Cavelti-Weder via Crossref Metadata Search

Peer review (4 reviews for 4 publications/grants)

Review activity for Cell metabolism. (1)
Review activity for Nature microbiology. (1)
Review activity for Nature reviews. (1)
Review activity for Peptides. (1)
How many people are using ORCID?